Sudhir Sahasrabudhe
Director/Board Member at Utah State University Foundation
Sudhir Sahasrabudhe active positions
Companies | Position | Start | End |
---|---|---|---|
Utah State University Foundation | Director/Board Member | - | - |
Massachusetts Institute of Technology | Corporate Officer/Principal | - | - |
Career history of Sudhir Sahasrabudhe
Former positions of Sudhir Sahasrabudhe
Companies | Position | Start | End |
---|---|---|---|
MYRIAD GENETICS, INC. | Chief Tech/Sci/R&D Officer | - | - |
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Chief Tech/Sci/R&D Officer | - | - |
Prolexys Pharmaceuticals, Inc.
Prolexys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prolexys Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering small molecule drugs that act at novel therapeutic targets. The Company's therapeutic focus is on cancer and cardiovascular indications. Prolexys scientists have exploited proprietary proteomics-related techniques to rapidly and accurately identify drug candidates that interact with targets of interest. The result of targeted drug discovery work at Prolexys is a pipeline of product candidates with high value in areas of unmet medical need. Lead programs include: a) Solid tumor oncology program with a small molecule clinical candidate with selective anti-tumor activity, b) The colon cancer program with novel small molecule compounds targeting the beta-catenin signaling cascade and c) HSP20 antagonists, identified as protein interaction inhibitors from targets validated in asthma and vasorelaxation. | Chief Executive Officer | 2000-12-31 | - |
Chief Tech/Sci/R&D Officer | 2000-12-31 | - |
Training of Sudhir Sahasrabudhe
University of Baroda | Graduate Degree |
Statistics
International
United States | 6 |
India | 2 |
Operational
Chief Tech/Sci/R&D Officer | 3 |
Chief Executive Officer | 1 |
Graduate Degree | 1 |
Sectoral
Health Technology | 4 |
Finance | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
MYRIAD GENETICS, INC. | Health Technology |
Private companies | 3 |
---|---|
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Health Technology |
Prolexys Pharmaceuticals, Inc.
Prolexys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prolexys Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering small molecule drugs that act at novel therapeutic targets. The Company's therapeutic focus is on cancer and cardiovascular indications. Prolexys scientists have exploited proprietary proteomics-related techniques to rapidly and accurately identify drug candidates that interact with targets of interest. The result of targeted drug discovery work at Prolexys is a pipeline of product candidates with high value in areas of unmet medical need. Lead programs include: a) Solid tumor oncology program with a small molecule clinical candidate with selective anti-tumor activity, b) The colon cancer program with novel small molecule compounds targeting the beta-catenin signaling cascade and c) HSP20 antagonists, identified as protein interaction inhibitors from targets validated in asthma and vasorelaxation. | Health Technology |
Utah State University Foundation |
- Stock Market
- Insiders
- Sudhir Sahasrabudhe
- Experience